Oslo, 8 July 2020: Reference is made to Navamedic ASA's (the "Company") stock exchange announcement published on 10 June 2020 regarding the board of directors' resolution to increase the Company's share capital in connection with the completion of an exercise period for vested shares under the Company's 2018 option program.
The share capital increase pertaining to the exercise period has now been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The new share capital of the Company is NOK 11,223,494.90, divided into 15,166,885 shares, each with a par value of NOK 0.74.
Following the registration of the new shares in the Norwegian Central Securities Depository (the VPS), which is expected to take place today, on 8 July 2020, the new shares will be delivered to the subscribers and listed on the Oslo Stock Exchange.
For further information, please contact:
Lars Hjarrand, CFO, Navamedic,
Mobile: +47 917 62 842
E-mail: lars.hjarrand@navamedic.com
About Navamedic
Navamedic ASA is a preferred, full-service provider of high-quality healthcare products to hospitals and pharmacies. Navamedic meets the specific medical needs of patients and consumers by leveraging its highly scalable market access platform, leading category competence and local knowledge. Navamedic is present in all the Nordic countries, the Baltics and Benelux, with sales representation in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (ticker: NAVA). For more information, please visit www.navamedic.com
This information is published pursuant to the continuing obligations of the Oslo Stock Exchange.